肺结核治疗后感染性并发症研究进展
Research Progress of Infectious Complications after Pulmonary Tuberculosis Treatment
DOI: 10.12677/ACM.2021.117469, PDF,   
作者: 李 嫒：青海大学，青海 西宁；崔金霞*：青海大学附属医院呼吸内科，青海 西宁
关键词: 肺结核；非结核分枝杆菌；支气管扩张症；Pulmonary Tuberculosis； Non-Tuberculous Mycobacterium； Bronchiectasis
摘要: 随着人们对已治疗的肺结核患者更多关注与随访，发现感染更有可能发生在这类患者中。因为肺结核是一个破坏性的过程，会导致肺组织纤维化、实质改变、支气管扩张、肺部瘢痕形成等，导致肺体积减少，进而影响肺功能。除了结核病的复发和再次感染外，对于治疗后的结核病患者还越来越多地认识到其他病原体的感染。本文旨在总结如何处理新发肺部感染的肺结核患者，以确保最佳的治疗和康复。
Abstract: With the increasing attention and follow-up to patients who have been treated for pulmonary tuberculosis, infection is more likely to occur in these patients. Because TB is a destructive process, it can lead to fibrosis of lung tissue, parenchymal changes, bronchiectasis, scarring of the lungs, resulting in reduced lung volume, which in turn affects lung function. In addition to the recurrence and re-infection of TB, patients following TB treatment are increasingly aware of infection with other pathogens. The purpose of this article is to summarize and guide the management of pulmonary tuberculosis patients with new signs and symptoms of pulmonary infection to ensure optimal treatment and recovery.
文章引用：李嫒, 崔金霞. 肺结核治疗后感染性并发症研究进展[J]. 临床医学进展, 2021, 11(7): 3232-3237. https://doi.org/10.12677/ACM.2021.117469

参考文献

[1] Furin, J., Cox, H. and Pai, M. (2019) Tuberculosis. The Lancet, 393, 1642-1656. [Google Scholar] [CrossRef] 
[2] Hnizdo, E., Singh, T. and Churchyard, G. (2000) Chronic Pulmonary Function Impairment Caused by Initial and Recurrent Pulmonary Tuberculosis Following Treatment. Thorax, 55, 32-38. [Google Scholar] [CrossRef] [PubMed]
[3] Amaral, A.F., Coton, S., Kato, B., et al. (2015) Tuberculosis Associates with Both Airflow Obstruction and Low Lung Function: BOLD Results. European Respiratory Journal, 46, 1104-1112. [Google Scholar] [CrossRef] [PubMed]
[4] Byrne, A.L., Marais, B.J., Mitnick, C.D., et al. (2015) Tuberculosis and Chronic Respiratory Disease: A Systematic Review. International Journal of Infectious Diseases, 32, 138-146. [Google Scholar] [CrossRef] [PubMed]
[5] Gläser, S., Krüger, S., Merkel, M., et al. (2015) Chronic Obstructive Pulmonary Disease and Diabetes Mellitus: A Systematic Review of the Literature. Respiration, 89, 253-264. [Google Scholar] [CrossRef] [PubMed]
[6] Brode, S.K., Daley, C.L. and Marras, T.K. (2014) The Epidemiologic Relationship between Tuberculosis and Non-Tuberculous Mycobacterial Disease: A Systematic Review. International Journal of Tuberculosis and Lung Disease, 18, 1370-1377. [Google Scholar] [CrossRef] [PubMed]
[7] Jhun, B.W., Jung, W.J., Hwang, N.Y., et al. (2017) Risk Factors for the Development of Chronic Pulmonary Aspergillosis in Patients with Nontuberculous Mycobacterial Lung Disease. PLoS ONE, 12, e188716. [Google Scholar] [CrossRef] [PubMed]
[8] Naito, M., Kurahara, Y., Yoshida, S., et al. (2018) Prognosis of Chronic Pulmonary Aspergillosis in Patients with Pulmonary Non-Tuberculous Mycobacterial Disease. Respiratory Investigation, 56, 326-331. [Google Scholar] [CrossRef] [PubMed]
[9] (1970) Aspergilloma and Residual Tuberculous Cavities—The Results of a Resurvey. Tubercle, 51, 227-245. [Google Scholar] [CrossRef] 
[10] Lowes, D., Al-Shair, K., Newton, P.J., et al. (2017) Predictors of Mortality in Chronic Pulmonary Aspergillosis. European Respiratory Journal, 49, Article ID: 1601062. [Google Scholar] [CrossRef] [PubMed]
[11] Ohba, H., Miwa, S., Shirai, M., et al. (2012) Clinical Characteristics and Prognosis of Chronic Pulmonary Aspergillosis. Respiratory Medicine, 106, 724-729. [Google Scholar] [CrossRef] [PubMed]
[12] Schweer, K.E., Bangard, C., Hekmat, K., et al. (2014) Chronic Pulmonary Aspergillosis. Mycoses, 57, 257-270. [Google Scholar] [CrossRef] [PubMed]
[13] Desai, S.R., Hedayati, V., Patel, K., et al. (2015) Chronic Aspergillosis of the Lungs: Unravelling the Terminology and Radiology. European Radiology, 25, 3100-3107. [Google Scholar] [CrossRef] [PubMed]
[14] Denning, D.W., Page, I.D., Chakaya, J., et al. (2018) Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings. Emerging Infectious Diseases, 24, e171312. [Google Scholar] [CrossRef] [PubMed]
[15] Takazono, T. and Izumikawa, K. (2018) Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis. Frontiers in Microbiology, 9, 1810. [Google Scholar] [CrossRef] [PubMed]
[16] Denning, D.W., Cadranel, J., Beigelman-Aubry, C., et al. (2016) Chronic Pulmonary Aspergillosis: Rationale and Clinical Guidelines for Diagnosis and Management. European Respiratory Journal, 47, 45-68. [Google Scholar] [CrossRef] [PubMed]
[17] Maghrabi, F. and Denning, D.W. (2017) The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach. Current Fungal Infection Reports, 11, 242-251. [Google Scholar] [CrossRef] [PubMed]
[18] Patterson, T.F., Thompson, G.R., Denning, D.W., et al. (2016) Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 63, e1-e60. [Google Scholar] [CrossRef] [PubMed]
[19] Ullmann, A.J., Aguado, J.M., Arikan-Akdagli, S., et al. (2018) Diagnosis and Management of Aspergillus Diseases: Executive Summary of the 2017 ESCMID-ECMM-ERS Guideline. Clinical Microbiology and Infection, 24, e1-e38. [Google Scholar] [CrossRef] [PubMed]
[20] Godet, C., Laurent, F., Bergeron, A., et al. (2016) CT Imaging Assessment of Response to Treatment in Chronic Pulmonary Aspergillosis. Chest, 150, 139-147. [Google Scholar] [CrossRef] [PubMed]
[21] Meghji, J., Simpson, H., Squire, S.B., et al. (2016) A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease. PLoS ONE, 11, e161176. [Google Scholar] [CrossRef] [PubMed]
[22] Kim, H.Y., Song, K.S., Goo, J.M., et al. (2001) Thoracic Sequelae and Complications of Tuberculosis. Radiographics, 21, 839-858, 859-860. [Google Scholar] [CrossRef] [PubMed]
[23] Smith, M.P. (2017) Diagnosis and Management of Bronchiectasis. CMAJ, 189, E828-E835. [Google Scholar] [CrossRef] [PubMed]
[24] Dhar, R., Singh, S., Talwar, D., et al. (2019) Bronchiectasis in India: Results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. The Lancet Global Health, 7, e1269-e1279.
[25] Kenna, D., Lilley, D., Coward, A., et al. (2017) Prevalence of Burkholderia Species, Including Members of Burkholderia cepacia Complex, among UK Cystic and Non-Cystic Fibrosis Patients. Journal of Medical Microbiology, 66, 490-501. [Google Scholar] [CrossRef] [PubMed]
[26] Green, H. and Jones, A.M. (2015) The Microbiome and Emerging Pathogens in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis. Seminars in Respiratory and Critical Care Medicine, 36, 225-235. [Google Scholar] [CrossRef] [PubMed]
[27] Chandrasekaran, R., Mac, A.M., Chalmers, J.D., et al. (2018) Geographic Variation in the Aetiology, Epidemiology and Microbiology of Bronchiectasis. BMC Pulmonary Medicine, 18, 83. [Google Scholar] [CrossRef] [PubMed]
[28] Altenburg, J., de Graaff, C.S., Stienstra, Y., et al. (2013) Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations among Patients with Non-Cystic Fibrosis Bronchiectasis: The BAT Randomized Controlled Trial. JAMA, 309, 1251-1259. [Google Scholar] [CrossRef] [PubMed]
[29] Serisier, D.J., Martin, M.L., McGuckin, M.A., et al. (2013) Effect of Long-Term, Low-Dose Erythromycin on Pulmonary Exacerbations among Patients with Non-Cystic Fibrosis Bronchiectasis: The BLESS Randomized Controlled Trial. JAMA, 309, 1260-1267. [Google Scholar] [CrossRef] [PubMed]
[30] Shah, N.M., Davidson, J.A., Anderson, L.F., et al. (2016) Pulmonary Mycobacterium avium-intracellulare Is the Main Driver of the Rise in Non-Tuberculous Mycobacteria Incidence in England, Wales and Northern Ireland, 2007-2012. BMC Infectious Diseases, 16, 195. [Google Scholar] [CrossRef] [PubMed]
[31] Fowler, S.J., French, J., Screaton, N.J., et al. (2006) Nontuberculous Mycobacteria in Bronchiectasis: Prevalence and Patient Characteristics. European Respiratory Journal, 28, 1204. [Google Scholar] [CrossRef] [PubMed]
[32] Hsing, S.C., Weng, S.F., Cheng, K.C., et al. (2013) Increased Risk of Pulmonary Tuberculosis in Patients with Previous Non-Tuberculous Mycobacterial Disease. International Journal of Tuberculosis and Lung Disease, 17, 928-933. [Google Scholar] [CrossRef] [PubMed]
[33] Swensen, S.J., Hartman, T.E. and Williams, D.E. (1994) Computed Tomographic Diagnosis of Mycobacterium avium-intracellulare Complex in Patients with Bronchiectasis. Chest, 105, 49-52. [Google Scholar] [CrossRef] [PubMed]
[34] Griffith, D.E., Aksamit, T., Brown-Elliott, B.A., et al. (2007) An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. American Journal of Respiratory and Critical Care Medicine, 175, 367-416. [Google Scholar] [CrossRef] 
[35] Haworth, C.S., Banks, J., Capstick, T., et al. (2017) British Thoracic Society Guidelines for the Management of Non-Tuberculous Mycobacterial Pulmonary Disease (NTM-PD). Thorax, 72, i1-i64. [Google Scholar] [CrossRef] [PubMed]
[36] Oei, W. and Nishiura, H. (2012) The Relationship between Tuberculosis and Influenza Death during the Influenza (H1N1) Pandemic from 1918-19. Computational and Mathematical Methods in Medicine, 2012, Article ID: 124861. [Google Scholar] [CrossRef] [PubMed]
[37] Zürcher, K., Zwahlen, M., Ballif, M., et al. (2016) Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland. PLoS ONE, 11, e162575. [Google Scholar] [CrossRef] [PubMed]
[38] Small, C.L., Shaler, C.R., McCormick, S., et al. (2010) Influenza Infection Leads to Increased Susceptibility to Subsequent Bacterial Superinfection by Impairing NK Cell Responses in the Lung. The Journal of Immunology, 184, 2048-2056. [Google Scholar] [CrossRef] [PubMed]
[39] Muñoz-Torrico, M., Rendon, A., Centis, R., et al. (2016) Is There a Rationale for Pulmonary Rehabilitation Following Successful Chemotherapy for Tuberculosis? Jornal Brasileiro de Pneumologia, 42, 374-385. [Google Scholar] [CrossRef] 
[40] Zhang, C., Wang, Y., Shi, G., et al. (2016) Determinants of Multidrug-Resistant Tuberculosis in Henan Province in China: A Case Control Study. BMC Public Health, 16, 42. [Google Scholar] [CrossRef] [PubMed]
[41] Chalmers, J.D., Aliberti, S. and Blasi, F. (2015) Management of Bronchiectasis in Adults. European Respiratory Journal, 45, 1446-1462. [Google Scholar] [CrossRef] [PubMed]

为你推荐